10-K Filing

SRX HEALTH SOLUTIONS, INC. CIK: 1471727 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001185185-15-003074`
Period End Date	20150831
Filing Date	20151118
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	senz-20150831.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 51 Income Statement 30 Cash Flow Statement 34 Stockholders Equity 13

Balance Sheet 51 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$2.19K	USD	Point-in-time
Equipment, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$4.38K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$2.19K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Total Assets	`Assets`	$4.38K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.58M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.58M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	60,200.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.58M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	60,200.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.58M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.73K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$21.32K	USD	Point-in-time
Convertible debt - related party	`ConvertibleNotesPayableCurrent`	$15.67K	USD	Point-in-time
Convertible debt - related party	`ConvertibleNotesPayableCurrent`	$38.54K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.87K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$37.40K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 20,000,000 shares authorized, 1,000 shares issued and outstanding as of August 31, 2015 and August 31, 2014	`PreferredStockValue`	$1.00	USD	Point-in-time
Preferred stock, $0.001 par value, 20,000,000 shares authorized, 1,000 shares issued and outstanding as of August 31, 2015 and August 31, 2014	`PreferredStockValue`	$1.00	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized, 37,581,903 and 37,581,903 shares issued and outstanding as of August 31, 2015 and August 31, 2014	`CommonStockValue`	$37.58K	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized, 37,581,903 and 37,581,903 shares issued and outstanding as of August 31, 2015 and August 31, 2014	`CommonStockValue`	$37.58K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$311.18K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$336.19K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-381.78K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-431.45K	USD	Point-in-time
Total (deficiency in) stockholders' equity	`StockholdersEquity`	$-33.02K	USD	Point-in-time
Total (deficiency in) stockholders' equity	`StockholdersEquity`	$-80.79K	USD	Point-in-time
Total (deficiency in) stockholders' equity	`StockholdersEquity`	$-57.67K	USD	Point-in-time
Total liabilities and (deficiency in) stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.38K	USD	Point-in-time
Total liabilities and (deficiency in) stockholders' equity	`LiabilitiesAndStockholdersEquity`	$2.19K	USD	Point-in-time

Income Statement 30 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	-	USD	Annual
Revenue	`SalesRevenueNet`	-	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.17K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$7.44K	USD	Annual
Professional fees	`ProfessionalFees`	$15.30K	USD	Annual
Professional fees	`ProfessionalFees`	$15.64K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$4.19K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$2.19K	USD	Annual
Total operating expenses	`OperatingExpenses`	$27.27K	USD	Annual
Total operating expenses	`OperatingExpenses`	$24.65K	USD	Annual
Net Operating Loss	`OperatingIncomeLoss`	$-27.27K	USD	Annual
Net Operating Loss	`OperatingIncomeLoss`	$-24.65K	USD	Annual
Interest expense	`InterestExpense`	$25.02K	USD	Annual
Interest expense	`InterestExpense`	$23.96K	USD	Annual
Total other expense	`OtherNonoperatingIncomeExpense`	$-25.02K	USD	Annual
Total other expense	`OtherNonoperatingIncomeExpense`	$-23.96K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-49.67K	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-51.24K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-49.67K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-51.24K	USD	Annual
Net income (loss) per share - basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	Annual
Net income (loss) per share - basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	Annual
Net income (loss) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	Annual
Net income (loss) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	Annual
Weighted average shares outstanding - basic (post-reverse split) (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	37.58M	shares	Annual
Weighted average shares outstanding - basic (post-reverse split) (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.77M	shares	Annual
Weighted average shares outstanding - diluted (post-reverse split) (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.58M	shares	Annual
Weighted average shares outstanding - diluted (post-reverse split) (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.77M	shares	Annual

Cash Flow Statement 34 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-49.67K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-51.24K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$4.19K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$2.19K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$22.64K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$22.88K	USD	Annual
Imputed interest	`ImputedInterestDebt`	$2.14K	USD	Annual
Imputed interest	`ImputedInterestDebt`	$1.32K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$462.00	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-411.00	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.62K	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.88K	USD	Annual
Proceeds from (repayments of) bank overdrafts	`ProceedsFromRepaymentsOfBankOverdrafts`	-	USD	Annual
Proceeds from (repayments of) bank overdrafts	`ProceedsFromRepaymentsOfBankOverdrafts`	$-22.00	USD	Annual
Proceeds from convertible debt - related party	`ProceedsFromConvertibleDebt`	$22.88K	USD	Annual
Proceeds from convertible debt - related party	`ProceedsFromConvertibleDebt`	$22.64K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.62K	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$22.88K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Discount on beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$22.88K	USD	Annual
Discount on beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$22.64K	USD	Annual
Stock issued for conversion of debt	`ReclassificationOfNotesPayableToConvertibleDebt`	$75.04K	USD	Annual
Stock issued for conversion of debt	`ReclassificationOfNotesPayableToConvertibleDebt`	-	USD	Annual

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-33.02K	USD	Point-in-time
Balance	`StockholdersEquity`	$-80.79K	USD	Point-in-time
Balance	`StockholdersEquity`	$-57.67K	USD	Point-in-time
Stock issued for conversion of debt	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$75.04K	USD	Annual
Imputed interest on convertible debt	`AdjustmentsToAdditionalPaidInCapitalOther`	$1.32K	USD	Annual
Imputed interest on convertible debt	`AdjustmentsToAdditionalPaidInCapitalOther`	$2.14K	USD	Annual
Discount related to beneficial conversion feature on convertible debt	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$22.64K	USD	Annual
Discount related to beneficial conversion feature on convertible debt	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$22.88K	USD	Annual
Net loss	`NetIncomeLoss`	$-49.67K	USD	Annual
Net loss	`NetIncomeLoss`	$-51.24K	USD	Annual
Balance	`StockholdersEquity`	$-33.02K	USD	Point-in-time
Balance	`StockholdersEquity`	$-80.79K	USD	Point-in-time
Balance	`StockholdersEquity`	$-57.67K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.